References

Barrett MJ, Murphy JM, Zhang J, Blair JC, Flanigan JL, Nawaz H, Dalrymple WA, Sperling SA, Patrie J, Druzgal TJ (2021) Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson disease. Parkinsonism Relat Disord 90:27-32. doi: 10.1016/j.parkreldis.2021.07.024

Summary: This study examined the relationship between olfaction, longitudinal change in cholinergic basal forebrain nuclei and their target regions, and cognition in early Parkinson’s Disease.

See: Linster C et al. Selective Loss of Cholinergic Neurons Projecting to the Olfactory System Increases Perceptual Generalization Between Similar, but Not Dissimilar, Odorants. Behav Neurosci 115(4):826-833, 2001.

Related Products: 192-IgG-SAP (Cat. #IT-01)

Borkowski LF, Smith CL, Keilholz AN, Nichols NL (2021) Divergent receptor utilization is necessary for phrenic long-term facilitation over the course of motor neuron loss following CTB-SAP intrapleural injections. J Neurophysiol 126(3):709-722. doi: 10.1152/jn.00236.2021

Objective: The authors tested the hypothesis that phrenic long-term facilitation (pLTF) following treatment with CTB-SAP is: 1) adenosine 2A (A2A) receptor-dependent at 7d; and 2) serotonin (5-HT) receptor-dependent at 28d.

Summary: This study furthers understanding of the contribution of differential receptor activation to pLTF and its implications for breathing following respiratory motor neuron death.

Usage: Male rats received bilateral, intrapleural injections of CTB-SAP or Saporin Control (25 μg).

Related Products: CTB-SAP (Cat. #IT-14), Saporin (Cat. #PR-01)

Jimenez-Martin J, Potapov D, Potapov K, Knöpfel T, Empson RM (2021) Cholinergic modulation of sensory processing in awake mouse cortex. Sci Rep 11(1):17525. doi: 10.1038/s41598-021-96696-8

Objective: To decipher the timing and significance of acetylcholine actions.

Summary: Study provides new insights into how the cortex processes sensory information and how loss of acetylcholine, for example in Alzheimer’s Disease, disrupts sensory behaviours.

Usage: Focal cortical injection of mu p75-SAP or Rabbit IgG-SAP (1.7 mg/ml, 0.3 µl total volume, rate 0.075 µl/minute).

Related Products: mu p75-SAP (Cat. #IT-16), Rabbit IgG-SAP (Cat. #IT-35)

Dai M, Nakamura S, Takahashi C, Sato M, Munetomo A, Magata F, Uenoyama Y, Tsukamura H, Matsuda F (2021) Reduction of arcuate kappa-opioid receptor-expressing cells increased luteinizing hormone pulse frequency in female rats. Endocr J 68(8):933-941. doi: 10.1507/endocrj.EJ20-0832

Summary: The number of Kiss1-expressing cells in the ARC was not affected by ARC Dyno-SAP treatment. Dynorphin-Kappa opioid receptor (KOR) signaling within the ARC seems to mediate the suppression of the frequency of pulsatile GnRH/LH release, and neurons in the hypothalamic arcuate nucleus (ARC) non-KNDy KOR neurons may be involved in the mechanism modulating GnRH/LH pulse generation.

Usage: Female rats were stereotaxically injected with Dyno-SAP (20 ng/200 nL) or unconjugated Saporin (18.6 ng/200 nL) as a control, bilaterally into the anterior and posterior ARC (total of 4 injection sites).

Related Products: Dyno-SAP (Dynorphin-SAP) (Cat. #IT-68), Saporin (Cat. #PR-01)

Wiedlocha A, Haugsten EM, Zakrzewska M (2021) Roles of the FGF-FGFR signaling system in cancer development and inflammation. Cells 10(9):2231. doi: 10.3390/cells10092231 PMID: 34571880

Objective: To highlight the latest advances in understanding the role of the FGF-FGFR signaling system in the development of neoplastic diseases and in the induction and maintenance of inflammation and its sequelae.

Related Products: FGF-SAP (Cat. #IT-38)

Sangartit W, Ha KB, Lee ES, Kim HM, Kukongviriyapan U, Lee EY, Chung CH (2021) Tetrahydrocurcumin ameliorates kidney injury and high systolic blood pressure in high-fat diet-induced type 2 diabetic mice. Endocrinol Metab (Seoul) 36(4):810-822. doi: 10.3803/EnM.2021.988 PMID: 34474516

Objective: To investigate the protective effect of tetrahydrocurcumin (THU) on intrarenal RAS expression, kidney injury, and systolic blood pressure (SBP) in high-fat diet (HFD)-induced type 2 diabetic mice.

Summary: THU alleviated kidney injury in mice with HFD-induced type 2 diabetes, possibly by blunting the activation of the intrarenal RAS/nicotinamide adenine dinucleotide phosphate oxidase IV (NOX4)/monocyte chemoattractant protein 1 (MCP-1) axis and by lowering the high SBP.

Usage: Western Blot (1:1000)

Related Products: Angiotensin II receptor (AT-2R) Rabbit Polyclonal, affinity-purified (Cat. #AB-N28AP)

Han D, Shi Y, Han F (2022) The effects of orexin-A and orexin receptors on anxiety- and depression-related behaviors in a male rat model of post-traumatic stress disorder. J Comp Neurol 530(3):592-606. doi: 10.1002/cne.25231

Objective: To determine the role of the orexin system in mediating anxiety- and depression-related behaviors in PTSD.

Summary: Intracerebroventricular administration of orexin-A alleviated behavioral changes in a PTSD rat model and partly restored the increased levels of OX1R in the medial prefrontal cortex (mPFC). These results suggest that the orexin system plays a role in the anxiety- and depression-related symptoms observed in PTSD.

See: Kaur S et al. Hypocretin-2 saporin lesions of the ventrolateral periaquaductal gray (vlPAG) increase REM sleep in hypocretin knockout mice. PLoS One 4:e6346, 2009.

Related Products: Orexin-B-SAP (Cat. #IT-20)

Dookwah M, Wagner SK, Ishihara M, Yu SH, Ulrichs H, Kulik MJ, Zeltner N, Dalton S, Strauss KA, Aoki K, Steet R, Tiemeyer M (2021) Neural-specific alterations in glycosphingolipid biosynthesis and cell signaling associated with two human ganglioside GM3 Synthase Deficiency variants. bioRxiv 2021.07.29.454399. doi: 10.1101/2021.07.29.454399

Related Products: NGFr (ME20.4, p75) Mouse Monoclonal (Cat. #AB-N07)

Mori A, Cross B, Uchida S, Kerrick Walker J, Ristuccia R (2021) How are adenosine and adenosine A2A receptors involved in the pathophysiology of amyotrophic lateral sclerosis?. Biomedicines 9(8):1027. doi: 10.3390/biomedicines9081027

Objective: To examine potential biomarkers and the acute symptomatic pharmacology, including respiratory motor neuron control, of adenosine A2A receptor antagonism, and to explore the potential of the A2A receptor as a target for Amyotrophic Lateral Sclerosis (ALS) therapy.

Summary: CTB-SAP is listed in a table of experimental animal models of ALS. Intrapleural CTB-SAP injected rats (neurotoxic model of respiratory motor neuron death).

See: Seven YB et al. Adenosine 2A receptor inhibition protects phrenic motor neurons from cell death induced by protein synthesis inhibition. Exp Neurol 323:113067, 2020.

Related Products: CTB-SAP (Cat. #IT-14)

Bloch JS, Sequeira JM, Ramírez AS, Quadros EV, Locher KP (2021) Generation of nanobodies targeting the human, transcobalamin-mediated vitamin B12 uptake route. bioRxiv 2021.08.16.456495. doi: 10.1101/2021.08.16.456495

Related Products: Streptavidin-ZAP (Cat. #IT-27)